Company overview
Lunaphore, a Bio-Techne brand, offers the COMET™ platform for fully automated, high-throughput hyperplex spatial biology, enabling analysis of up to 40 spatial markers per tissue slide using off-the-shelf antibodies. It supports multiplex immunofluorescence, IHC, and multiomics workflows combining RNA and protein detection in the same tissue section for pharma R&D in immuno-oncology, biomarker discovery, and translational research. The platform ensures reproducibility, full tissue preservation, and scalability for clinical trials through partnerships like Discovery Life Sciences.
Multiplex Solutions is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include lunaphore comet, spatial biology, multiplex immunofluorescence, hyperplex platform, pharma r&d vendors.
Structured facts
- Website
- https://lunaphore.com/
- Markets served
- United States & Americas
- Keywords
- lunaphore comet, spatial biology, multiplex immunofluorescence, hyperplex platform, pharma r&d vendors
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What are the key capabilities of Lunaphore's COMET platform?
- COMET provides fully automated hyperplex immunofluorescence for up to 40 markers per slide, multiomics RNA/protein detection, and uses off-the-shelf antibodies with full tissue preservation for downstream analysis.
- Is Lunaphore's technology suitable for clinical research and regulatory compliance?
- Yes, through partnerships like Discovery Life Sciences, COMET supports clinical trials with reproducible, high-throughput spatial profiling for biomarker discovery and patient stratification in immuno-oncology.
- What geographies does Lunaphore serve?
- As a Swiss company and Bio-Techne brand, Lunaphore operates globally, partnering with networks like Discovery Life Sciences for biospecimen and lab services worldwide.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
